icensing agreement with Emma Lewisham

3 October 2023 Licensing agreement with Emma Lewisham On 16 August 2023 Blis Technologies (NZX: BLT) announced a licensing agreement with a significant Australasian cosmetic skincare company to license our cosmetic facial live probiotic serum formulation containing BLIS Q24(R). The agreement is with Emma Lewisham, a fast-growing cosmetic skincare company known for its "science-led natural skincare that is certified climate positive." The agreement allows for an exclusive license to use the cosmetic live probiotic formulation under the Emma Lewisham brand in New Zealand, Australia and the United Kingdom, markets where Emma Lewisham has developed a strong retail and online presence. Emma Lewisham's product offer "Supernatural Blemish Serum with live probiotic" will be launched within retail and online from 3 October 2023. Blis CEO Brian Watson said "We are thrilled to see the launch of our first Business to Business partnership for our skincare technology. The Emma Lewisham brand is well regarded internationally and we look forward to supporting their growth plans with this unique product offer." Ends About the BLIS Q24(TM) Live Probiotic Serum Technology Enriched with a live probiotic in a shelf-stable topical format, the BLIS Q24(TM) Live Probiotic Serum has been shown to address various skin concerns and help to maintain a healthier, more radiant complexion. BLIS Q24(TM) is a patented strain of Micrococcus luteus, a commensal and beneficial species of bacterium naturally found on the skin. The strain was isolated in 2004 by Professor Emeritus John Tagg, who recognised its ability to inhibit the growth of key skin pathogens associated with skin diseases. Website: www.blis.co.nz Instagram: @blisprobiotics #blisk12 #blism18 #blisq24 Facebook: @BLISProbiotics End CA:00419294 For:BLT Type:MKTUPDTE Time:2023-10-03 08:41:47